Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats

par Nassar, Ala F., Wisnewski, Adam, King, Ivan
Publié dans Xenobiotica (2015)

Impact of recent innovations in the use of mass cytometry in support of drug development

par Nassar, Ala F., Ogura, Hideki, Wisnewski, Adam V.
Publié dans Drug Discov Today (2015)

Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization

par Nassar, Ala F., Wisnewski, Adam V., Raddassi, Khadir
Publié dans Anal Bioanal Chem (2017)

LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2’ and 2,4’ vs. 4,4’) of Methylene Diphenyl-Diisocyanate

par Wisnewski, Adam V, Liu, Jian, Nassar, Ala F
Publié dans EC Pharmacol Toxicol (2019)

Di-Lysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

par Wisnewski, Adam V., Nassar, Ala F, Liu, Jian, Bello, Dhimiter
Publié dans Chem Res Toxicol (2019)

UPLC–MS for metabolomics: a giant step forward in support of pharmaceutical research

par Nassar, Ala F., Wu, Terence, Nassar, Samuel F., Wisnewski, Adam V.
Publié dans Drug Discov Today (2016)

Polymerization of hexamethylene diisocyanate in solution and a 260.23 m/z [M+H](+) ion in exposed human cells

par Wisnewski, Adam V, Liu, Jian, Redlich, Carrie A, Nassar, Ala F
Publié dans Anal Biochem (2017)

Reaction products of hexamethylene diisocyanate vapors with “self” molecules in the airways of rabbits exposed via tracheostomy

par Wisnewski, Adam V., Kanyo, Jean, Asher, Jennifer, Goodrich, James A., Barnett, Grace, Patrylak, Lyn, Liu, Jian, Redlich, Carrie A., Nassar, Ala F.
Publié dans Xenobiotica (2017)